期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 7, 期 12, 页码 1717-1727出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.7.12.1717
关键词
apoptosis; marker panel; multimarker analysis; p53; protein expression; retinoblastoma; urothelial carcinoma
类别
资金
- NCI NIH HHS [CA-103455, CA-14089, CA-70903, CA-86871, CA-71921] Funding Source: Medline
Bladder cancer is the seventh most common malignancy worldwide, with almost 14,000 patients dying from this disease in the USA alone. Because of the need for long-term and frequent follow-up, as well as the paucity of sensitive and specific noninvasive tests, bladder cancer management has the highest cost per patient among all cancer types. Several molecular markers, especially members of the cell cycle regulation and apoptosis pathways, have been investigated. However, no individual marker has been prognostically powerful enough to change clinical management. The combined analysis of a panel of markers spanning different pathways is the most promising approach. We give an overview of the most important molecular markers functioning in crucial pathways and focus on their role in multimarker analysis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据